Related Experiment Video
Updated: Jul 6, 2025

Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum
Published on: May 3, 2024
Pyroptosis in microbial infectious diseases
Cui Xiao1, Saihong Cao1,2, Yunfei Li1
1Department of Public Health Laboratory Sciences, School of Public Health, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.
Pyroptosis, a programmed cell death, is crucial for immune regulation during microbial infections. Targeting pyroptosis offers potential therapeutic strategies for infectious diseases caused by bacteria, viruses, and fungi.
Area of Science:
- Immunology
- Cell Biology
- Microbiology
Background:
- Pyroptosis is a critical gasdermin-mediated programmed cell death pathway involved in immune responses.
- Its roles in autoimmune diseases and cancer are well-established.
- Emerging evidence links microbial infections to pyroptosis, influencing disease pathogenesis.
Purpose of the Study:
- To review recent advancements in understanding pyroptosis during bacterial, viral, and fungal infections.
- To explore the association between pyroptosis and the development of microbial infectious diseases.
- To discuss potential therapeutic strategies targeting pyroptosis for infectious diseases.
Main Methods:
- Literature review of recent studies on pyroptosis and microbial infections.
- Analysis of the mechanisms linking microbial pathogens to pyroptosis induction.
- Exploration of therapeutic interventions targeting the pyroptosis pathway.
Main Results:
- Pyroptosis is implicated in the host immune response to a wide range of microbial pathogens.
- Dysregulation of pyroptosis can exacerbate microbial infectious diseases.
- Targeting pyroptosis demonstrates promise in preclinical models of infection.
Conclusions:
- Pyroptosis is a key cellular process in the context of microbial infections.
- Modulating pyroptosis presents a viable therapeutic avenue for treating infectious diseases.
- Further research is warranted to translate pyroptosis-targeting therapies into clinical practice.
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Pneumonia II: Pathophysiology
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

